GlassScriptPhysician profile
James V Worthen
NPI 1922217215
$4,482.50
in general payments reported to CMS, 2019-2025
22 companies · $469 in 2025
The $469 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,425 · 2020: $54.80 · 2021: $1,717 · 2022: $310 · 2023: $309 · 2024: $199 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,928.95 | 2019-2023 | Mako |
| Depuy Synthes Sales INC. | $237.07 | 2022-2025 | Dynatape, Healix Knotless Peek, Gryphon Orthocord |
| Pacira Therapeutics, INC. | $202.12 | 2019-2021 | |
| Orthalign INC | $202.01 | 2025 | Orthalign Plus |
| Innovation Technologies INC | $168.43 | 2022 | |
| Sanara Medtech INC. | $161.97 | 2023-2025 | Celleraterx, Biasurge |
| Biocomposites INC | $121.33 | 2023 | Stimulan |
| Vertex Pharmaceuticals Incorporated | $57.33 | 2024-2025 | |
| Heraeus Medical, LLC. | $50.93 | 2019 | |
| Arthrex, INC. | $49.90 | 2019 | |
| Ethicon US, LLC | $40.45 | 2021-2025 | Stratafix, Vistaseal, Ethicon |
| Heron Therapeutics, INC. | $33.54 | 2021-2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $33.01 | 2025 | Zilretta |
| Spr Therapeutics, INC | $31.20 | 2024 | Sprint Pns System |
| Kowa Pharmaceuticals America, INC. | $31.12 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $27.12 | 2025 | Visiclear, Abc Handpieces |
| Molnlycke Health Care US, LLC | $25.76 | 2025 | Mepilex Border Post-Op Ag |
| Ermi LLC | $18.60 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.69 | 2021 | |
| Bioventus LLC | $16.17 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.28 | 2019 | |
| Vericel Corporation | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Worthen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.